The EU’s drug regulator says it has discovered a “possible link” between the AstraZeneca coronavirus vaccine and a uncommon clotting dysfunction however stated that the advantages of the shot nonetheless outweigh dangers.
In an announcement launched Wednesday, the European Medicines Agency positioned no new restrictions on utilizing the vaccine in folks 18 and over.
The EMA stated many of the instances reported have occurred in girls below 60 inside two weeks of vaccination. The company stated primarily based on the presently accessible proof, it was not in a position to establish particular threat components. Experts reviewed a number of dozen instances that got here primarily from Europe and the United Kingdom, the place round 25 million folks have obtained the AstraZeneca vaccine.
“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” stated Emer Cooke, the company’s govt director.
Read all of the Latest News and Breaking News right here
